Japan has reached an agreement with AstraZeneca to receive a supply of 120 million doses of a coronavirus vaccine being developed with the University of Oxford, reported Kyodo News+.
According to the news source, the AZD1222 vaccine will be supplied to Japan from next year if put into practical use, with 30 million doses to be received by March.
Japan has already agreed to receive a supply of 120 million doses of a coronavirus vaccine for 60 million people by the end of June next year from Pfizer and its partner BioNTech, if they succeed in developing it.
AstraZeneca has announced that it will start supplying its COVID-19 vaccine overseas in September, and is expected to begin clinical trials in Japan later this month to confirm its efficacy and safety.
The UK drugmaker is also in talks with JCR Pharmaceuticals Co. to produce vaccine solutions, and with Daiichi Sankyo for packing and storing vaccines.